South Dakota Investment Council Lowers Position in Humana Inc. $HUM

South Dakota Investment Council lowered its stake in Humana Inc. (NYSE:HUM) by 9.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 148,842 shares of the insurance provider’s stock after selling 16,412 shares during the quarter. Humana comprises about 0.8% of South Dakota Investment Council’s portfolio, making the stock its 14th biggest holding. South Dakota Investment Council owned about 0.12% of Humana worth $38,724,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Elevation Point Wealth Partners LLC purchased a new stake in Humana in the second quarter valued at approximately $32,000. Mather Group LLC. purchased a new position in Humana in the third quarter valued at $34,000. Private Wealth Management Group LLC grew its stake in Humana by 47.5% during the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 48 shares in the last quarter. AlphaCore Capital LLC purchased a new stake in Humana during the 2nd quarter worth about $39,000. Finally, SJS Investment Consulting Inc. raised its position in Humana by 19,300.0% in the 3rd quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider’s stock valued at $50,000 after purchasing an additional 193 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on HUM. Jefferies Financial Group lowered their price objective on Humana from $310.00 to $235.00 and set a “buy” rating for the company in a research report on Thursday, February 12th. The Goldman Sachs Group reduced their price objective on shares of Humana from $215.00 to $158.00 and set a “sell” rating on the stock in a report on Friday, February 13th. TD Cowen decreased their price objective on shares of Humana from $260.00 to $173.00 and set a “hold” rating for the company in a research report on Friday, February 13th. Royal Bank Of Canada lowered Humana from an “outperform” rating to a “sector perform” rating and dropped their target price for the company from $322.00 to $189.00 in a report on Thursday, February 12th. Finally, JPMorgan Chase & Co. decreased their price target on Humana from $274.00 to $180.00 and set a “neutral” rating for the company in a report on Friday, February 13th. Seven analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat.com, Humana currently has a consensus rating of “Hold” and an average price target of $225.48.

Humana Stock Down 1.8%

Shares of NYSE HUM opened at $187.20 on Tuesday. The company has a quick ratio of 2.00, a current ratio of 2.00 and a debt-to-equity ratio of 0.70. Humana Inc. has a 52-week low of $169.61 and a 52-week high of $315.35. The business has a 50-day moving average price of $227.93 and a 200 day moving average price of $255.02. The stock has a market cap of $22.58 billion, a PE ratio of 19.06, a price-to-earnings-growth ratio of 1.93 and a beta of 0.44.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($4.01) by $0.05. Humana had a net margin of 0.92% and a return on equity of 11.43%. The business had revenue of $32.64 billion for the quarter, compared to analyst estimates of $32.08 billion. During the same period last year, the firm posted ($2.16) earnings per share. The company’s revenue for the quarter was up 11.3% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. Equities research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 27th. This represents a $3.54 annualized dividend and a yield of 1.9%. Humana’s dividend payout ratio is currently 36.05%.

Insiders Place Their Bets

In related news, insider Sanjay K. Shetty bought 810 shares of the stock in a transaction on Monday, February 23rd. The shares were bought at an average cost of $185.21 per share, for a total transaction of $150,020.10. Following the purchase, the insider owned 11,657 shares of the company’s stock, valued at $2,158,992.97. This trade represents a 7.47% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.37% of the company’s stock.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.